249 related articles for article (PubMed ID: 8970203)
1. p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder.
Takei K; Watanabe H; Itoi T; Saito T
Pathol Int; 1996 Nov; 46(11):908-17. PubMed ID: 8970203
[TBL] [Abstract][Full Text] [Related]
2. p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder.
Takei K; Watanabe H; Itoi T; Saito T
Pathol Int; 1996 Jun; 46(6):426-35. PubMed ID: 8869994
[TBL] [Abstract][Full Text] [Related]
3. Co-expression of gastric and biliary phenotype in pyloric-gland type adenoma of the gallbladder: immunohistochemical analysis of mucin profile and CD10.
Nagata S; Ajioka Y; Nishikura K; Watanabe G; Inoue T; Yamaguchi K; Watanabe H; Tanaka M; Tsuneyoshi M
Oncol Rep; 2007 Apr; 17(4):721-9. PubMed ID: 17342306
[TBL] [Abstract][Full Text] [Related]
4. Histological and genetic changes in malignant transformation of gallbladder adenoma.
Watanabe H; Date K; Itoi T; Matsubayashi H; Yokoyama N; Yamano M; Ajioka Y; Nishikura K
Ann Oncol; 1999; 10 Suppl 4():136-9. PubMed ID: 10436806
[TBL] [Abstract][Full Text] [Related]
5. Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2.
Nagao T; Sugano I; Ishida Y; Hasegawa M; Matsuzaki O; Konno A; Kondo Y; Nagao K
Cancer; 1998 Feb; 82(3):439-47. PubMed ID: 9452259
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and immunoexpression of p53, MIB-1 and proliferating cell nuclear antigen in adrenal neoplasms.
Martins AC; Cologna AJ; Tucci S; Suaid HJ; Falconi RA
J Urol; 2005 Jun; 173(6):2138-42. PubMed ID: 15879867
[TBL] [Abstract][Full Text] [Related]
7. p53 expression patterns in colorectal adenomas and early carcinomas: a special reference to depressed adenoma and non-polypoid carcinoma.
Yao T; Utsunomiya T; Nagai E; Oya M; Tsuneyoshi M
Pathol Int; 1996 Dec; 46(12):962-7. PubMed ID: 9110348
[TBL] [Abstract][Full Text] [Related]
8. p53 immunostaining distinguishes malignant from benign lesions of the gall-bladder.
Oohashi Y; Watanabe H; Ajioka Y; Hatakeyama K
Pathol Int; 1995 Jan; 45(1):58-65. PubMed ID: 7704245
[TBL] [Abstract][Full Text] [Related]
9. Carcinoma of the ampulla of Vater associated with or without adenoma: a clinicopathologic analysis of 198 cases with reference to p53 and Ki-67 immunohistochemical expressions.
Takashima M; Ueki T; Nagai E; Yao T; Yamaguchi K; Tanaka M; Tsuneyoshi M
Mod Pathol; 2000 Dec; 13(12):1300-7. PubMed ID: 11144926
[TBL] [Abstract][Full Text] [Related]
10. [Cyclo-oxygenase-2 and p53 immunoreactivity in superficial early colorectal carcinoma].
Kim YS; Lim SD; Lee JK; Kim SE; Ryu SH; Lee JW; Moon JS
Korean J Gastroenterol; 2006 May; 47(5):350-6. PubMed ID: 16714876
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of proliferative activity, DNA ploidy pattern and p53 products as diagnostic adjuncts in colorectal adenomas and intramucosal carcinomas.
Sugai T; Nakamura SI; Habano W; Uesugi N; Sato H; Yoshida T; Orii S
Pathol Int; 1999 Jul; 49(7):617-25. PubMed ID: 10504522
[TBL] [Abstract][Full Text] [Related]
12. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
[TBL] [Abstract][Full Text] [Related]
13. Analysis of mucin, p53 protein and Ki-67 expressions in gastric differentiated-type intramucosal neoplastic lesions obtained from endoscopic mucosal resection samples: a proposal for a new classification of intramucosal neoplastic lesions based on nuclear atypia.
Sugai T; Inomata M; Uesugi N; Jiao YF; Endoh M; Orii S; Nakamura S
Pathol Int; 2004 Jun; 54(6):425-35. PubMed ID: 15144402
[TBL] [Abstract][Full Text] [Related]
14. Clinical importance of p53 protein in gall bladder carcinoma and its precursor lesions.
Wee A; Teh M; Raju GC
J Clin Pathol; 1994 May; 47(5):453-6. PubMed ID: 8027399
[TBL] [Abstract][Full Text] [Related]
15. Adenocarcinoma of gallbladder: an immunohistochemical profile and comparison with cholangiocarcinoma.
Hughes NR; Bhathal PS
J Clin Pathol; 2013 Mar; 66(3):212-7. PubMed ID: 23268317
[TBL] [Abstract][Full Text] [Related]
16. P53 and Ki-67 antigen expression in small oral biopsy specimens of salivary gland tumors.
Lazzaro B; Cleveland D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 May; 89(5):613-7. PubMed ID: 10807720
[TBL] [Abstract][Full Text] [Related]
17. APC, K-ras codon 12 mutations and p53 gene expression in carcinoma and adenoma of the gall-bladder suggest two genetic pathways in gall-bladder carcinogenesis.
Itoi T; Watanabe H; Ajioka Y; Oohashi Y; Takel K; Nishikura K; Nakamura Y; Horil A; Saito T
Pathol Int; 1996 May; 46(5):333-40. PubMed ID: 8809879
[TBL] [Abstract][Full Text] [Related]
18. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.
Thapar K; Scheithauer BW; Kovacs K; Pernicone PJ; Laws ER
Neurosurgery; 1996 Apr; 38(4):765-70; discussion 770-1. PubMed ID: 8692397
[TBL] [Abstract][Full Text] [Related]
19. Proliferation and apoptosis in proliferative lesions of the colon and rectum.
Kikuchi Y; Dinjens WN; Bosman FT
Virchows Arch; 1997 Aug; 431(2):111-7. PubMed ID: 9293892
[TBL] [Abstract][Full Text] [Related]
20. [Expression of p53 in gallbladder carcinoma and in dysplastic and metaplastic lesions of the surrounding mucosa].
Billo P; Marchegiani C; Capella C; Sessa F
Pathologica; 2000 Aug; 92(4):249-56. PubMed ID: 11029885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
